Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy

Science Translational Medicine(2021)10.1126/scitranslmed.abc8922Source: DataRank Database

Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy is a research paper published in Science Translational Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 157 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access157 citations

Download PDF

Cite:

Linked data & code

geo hpa doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (25 grants)Impact (FWCI 8.90)OA: greenTopics (51)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Wei Chen ORCID,Robert J. Torphy ORCID,Sheng Yao ORCID,Gefeng Zhu,Ronggui Lin

Live enrichment

PubMed:34321321 PMC:PMC8749958 OpenAlex:https://openalex.org/W3184342887

National Institutes of Health

Grant: DE028420

National Institutes of Health

Grant: CA196530

National Institutes of Health

Grant: HL143803

National Institutes of Health

Grant: P30CA046934

American Cancer Society

Grant: RSG-17-106-01 LIB

U.S. Department of Veterans Affairs

Grant: BX003232

U.S. Department of Veterans Affairs

Grant: NIH CA196530

U.S. Department of Veterans Affairs

Grant: NIH R01HL143803

U.S. Department of Veterans Affairs

Grant: NIH R01-DE028420

United Technologies

Grant: NIH P30CA046934

United Technologies

Grant: I01 BX003232

United Technologies

Grant: N/A

NCI NIH HHS

Grant: R01 CA203834

NIDCR NIH HHS

Grant: R01 DE028420

American Heart Association-American Stroke Association

Grant: 17IRG33400218

NCI NIH HHS

Grant: R01 CA260239

NCI NIH HHS

Grant: P50 CA196530

NHLBI NIH HHS

Grant: R01 HL137779

NCI NIH HHS

Grant: R01 CA200673

NHLBI NIH HHS

Grant: R01 HL143803

National Institutes of Health

Grant: 3P30CA046934-20S2

Cancer Center Support Grant

National Institutes of Health

Grant: 3P50CA196530-03S1

MicroRNA-based interventions to prevent progression from lung preneoplasia to adenocarcinoma

National Institutes of Health

Grant: 5R01DE028420-02

Mechanisms of dual inhibition of TGFbeta/PD-L1 in HNSCC

National Institutes of Health

Grant: 5R01HL143803-02

MicroRNA regulation of endothelial DNA repair to enhance anti-tumor immunity

United Technologies

FWCI

8.90

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

green

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8749958

publisherhttps://syndication.highwire.org/content/doi/10.1126/scitranslmed.abc8922

publisherhttps://www.science.org/doi/pdf/10.1126/scitranslmed.abc8922

journalhttps://doi.org/10.1126/scitranslmed.abc8922

Fields of Study

Cancer, Hypoxia, and MetabolismAngiogenesis and VEGF in CancerReceptor Mechanisms and Signaling0301 basic medicine03 medical and health sciencesAnimalsEndothelial CellsHumansImmunotherapyMiceNeoplasmsPharmaceutical PreparationsTumor Microenvironment

MeSH Terms

AnimalsPharmaceutical PreparationsHumansImmunotherapyNeoplasmsEndothelial CellsMiceTumor Microenvironment

Keywords

Tumor microenvironmentBlockadeImmunotherapyCancer researchMedicineTumor hypoxiaImmune systemImmunologyReceptorInternal medicineRadiation therapy570610Endothelial CellsBiological SciencesMedical and Health SciencesVaccine RelatedMiceGood Health and Well BeingPharmaceutical Preparations5.1 PharmaceuticalsNeoplasms2.1 Biological and endogenous factorsAnimalsHumansImmunizationAetiologyDevelopment of treatments and therapeutic interventionsBiotechnologyCancer

Sustainable Development Goals

SDG 2: 2. Zero hungerSDG 3: 3. Good healthSDG 0: Good health and well-being

Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy

FAIR Checklist

Authors (23)

Funding (25 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)